Similar Articles
771 Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation
772 New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
773 Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature
774 Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
775 Systematic review of cystic duct closure techniques in relation to prevention of bile duct leakage after laparoscopic cholecystectomy
776 Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
777 Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
778 Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
779 Pediatric hepatocellular carcinoma
780 Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA